- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05024786
The Effect of CQI on the Outcome of Patients Supported With ECMO
August 25, 2021 updated by: JinyanXing, The Affiliated Hospital of Qingdao University
The Effect of Continuous Quality Improvement on the Outcome of Patients Supported With Extracorporeal Membrane Oxygenation in ICU
This was a prospective observational study in comparison with a retrospective control group(Jan 2015 to Jun 2019).
Two ICUs in China were included.
The continuous quality improvement (CQI)strategies were implemented from Jul 2019 to Jun 2021(CQI group).
The mortalities of ECMO patients was compared between the CQI group and the control group.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
163
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Qingdao, Shandong, China, 266555
- The Affiliated Hospital of Qingdao University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients over 18 years old who received ECMO support in the centers between January 2015 and April 2021 were included, not including patients waiting for transplantation with ECMO.
Description
Inclusion Criteria:
- Patients over 18 years old who received ECMO support in the centers
Exclusion Criteria:
- patients waiting for transplantation with ECMO.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
control group
|
|
|
CQI group
|
We implement the continuous quality improvement strategy in CQI group, and observe the effect of the strategy on the mortality of patients supported with ECMO .
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The mortality of patients supported with ECMO
Time Frame: January, 2021 to July, 2021
|
January, 2021 to July, 2021
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2019
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
June 30, 2021
Study Registration Dates
First Submitted
August 23, 2021
First Submitted That Met QC Criteria
August 25, 2021
First Posted (Actual)
August 27, 2021
Study Record Updates
Last Update Posted (Actual)
August 27, 2021
Last Update Submitted That Met QC Criteria
August 25, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- QYFYKYLL931311921
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.